The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It

Front Endocrinol (Lausanne). 2021 Mar 11:12:636403. doi: 10.3389/fendo.2021.636403. eCollection 2021.

Abstract

The classic concept of how pituitary GH is regulated by somatostatin and GHRH has changed in recent years, following the discovery of peripheral hormones involved in the regulation of energy homeostasis and mineral homeostasis. These hormones are ghrelin, nesfatins, and klotho. Ghrelin is an orexigenic hormone, released primarily by the gastric mucosa, although it is widely expressed in many different tissues, including the central nervous system and the pituitary. To be active, ghrelin must bind to an n-octanoyl group (n = 8, generally) on serine 3, forming acyl ghrelin which can then bind and activate a G-protein-coupled receptor leading to phospholipase C activation that induces the formation of inositol 1,4,5-triphosphate and diacylglycerol that produce an increase in cytosolic calcium that allows the release of GH. In addition to its direct action on somatotrophs, ghrelin co-localizes with GHRH in several neurons, facilitating its release by inhibiting somatostatin, and acts synergistically with GHRH stimulating the synthesis and secretion of pituitary GH. Gastric ghrelin production declines with age, as does GH. Klotho is an anti-aging agent, produced mainly in the kidneys, whose soluble circulating form directly induces GH secretion through the activation of ERK1/2 and inhibits the inhibitory effect that IGF-I exerts on GH. Children and adults with untreated GH-deficiency show reduced plasma levels of klotho, but treatment with GH restores them to normal values. Deletions or mutations of the Klotho gene affect GH production. Nesfatins 1 and 2 are satiety hormones, they inhibit food intake. They have been found in GH3 cell cultures where they significantly reduce the expression of gh mRNA and that of pituitary-specific positive transcription factor 1, consequently acting as inhibitors of GH production. This is a consequence of the down-regulation of the cAMP/PKA/CREB signaling pathway. Interestingly, nesfatins eliminate the strong positive effect that ghrelin has on GH synthesis and secretion. Throughout this review, we will attempt to broadly analyze the role of these hormones in the complex world of GH regulation, a world in which these hormones already play a very important role.

Keywords: GHRH; IGF-I; ghrelin; growth hormone; klotho; nesfatins; somatostatin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Fatty Acids / metabolism
  • Gene Deletion
  • Ghrelin / metabolism
  • Ghrelin / physiology*
  • Growth Hormone / metabolism*
  • Growth Hormone-Releasing Hormone / metabolism
  • Human Growth Hormone / blood
  • Humans
  • Insulin-Like Growth Factor I / metabolism
  • Klotho Proteins / metabolism*
  • Mice
  • Mutation
  • Nucleobindins / metabolism*
  • Pituitary Gland / metabolism
  • Protein Domains
  • RNA, Messenger / metabolism
  • Rats
  • Receptors, Ghrelin / metabolism
  • Receptors, Pituitary Hormone-Regulating Hormone / metabolism
  • Signal Transduction / drug effects

Substances

  • Fatty Acids
  • GHRL protein, human
  • Ghrelin
  • KLB protein, human
  • NUCB2 protein, human
  • Nucleobindins
  • RNA, Messenger
  • Receptors, Ghrelin
  • Receptors, Pituitary Hormone-Regulating Hormone
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Growth Hormone
  • Growth Hormone-Releasing Hormone
  • Klotho Proteins